Biotechnology and Recombinant DNA Technology: Principles and Applications

Biotechnology and Genetic Engineering

Introduction to Biotechnology

Biotechnology is the field of applied biology in which living organisms, or processes derived from them, are used—often with human modification—to serve scientific, medical, or industrial purposes. This field is also known as genetic engineering or molecular biology when it involves direct manipulation of genetic material. Modern biotechnology relies heavily on foundational knowledge from genetics and molecular biology, especially from model organisms.

• Genetic engineering refers to the precise modification of an organism's genome by human intervention.

• Applications span medicine, agriculture, environmental science, and industry.

Areas of Biotechnology

• Medical biotechnology: Drug and vaccine production, genetic testing, pharmacogenomics, gene therapy, stem cell technology, cloning.

• Agricultural biotechnology: Genetically modified (GM) animals and plants for improved traits.

• Environmental biotechnology: Bioremediation using organisms to clean up pollutants.

• Genetic modification of humans: Emerging area with ethical considerations.

The biotechnology industry employs professionals from biology, chemistry, computer science, engineering, law, and business.

Genetically Modified Organisms (GMOs)

Definition and Historical Context

A genetically modified organism (GMO) is any organism whose genome has been altered by human intervention. While selective breeding has been practiced for thousands of years (e.g., domestication of corn, wheat, cows, and dogs), modern GMOs are created through precise molecular techniques.

• Modern genetic modification includes gene deletion, modification, replacement, or addition (from the same or different species—transgenic organisms).

Purposes of Creating GMOs

• Production of large quantities of proteins or drugs in bacteria, animals, or plants.

• Modification of phenotypes in animals or plants for desirable traits.

• Treatment of human diseases (e.g., gene therapy).

• Functional genomics: Knocking out or modifying genes to study their roles.

Recombinant DNA Technology

Drug Production in Genetically Modified Organisms

The first biotechnology company, Genentech, was founded in 1976 and pioneered gene cloning techniques. In 1977, the human insulin gene was cloned, leading to the production of Humulin (human insulin) in bacteria, which was approved in 1982. This replaced the need to purify insulin from animal sources.

Principles of Recombinant DNA Technology

• To express a human protein in bacteria, the gene of interest is placed downstream of a strong, inducible bacterial promoter (e.g., the lac promoter).

• DNA from different organisms is combined, hence the term recombinant DNA.

Plasmids as Vectors

Plasmids are small, circular, extrachromosomal DNA molecules found naturally in bacteria. They can replicate independently and often carry antibiotic resistance genes. In recombinant DNA technology, plasmids are engineered to carry foreign genes for expression in bacteria.

• Essential features of plasmid vectors:

  • Small size (1–5 kb)

  • Bacterial origin of replication (ori)

  • Selectable marker (e.g., antibiotic resistance gene)

  • Unique restriction sites for DNA insertion

  • Inducible promoter for gene expression

Restriction Enzymes and DNA Cloning

Restriction enzymes are proteins from bacteria that cut DNA at specific palindromic sequences (usually 4–8 base pairs). They are named after the organisms from which they were isolated (e.g., EcoRI from E. coli).

• They cut the sugar-phosphate backbone, producing either blunt ends or sticky ends (overhangs).

• Fragments with compatible ends can be joined by DNA ligase.

Restriction enzymes protect bacteria from foreign DNA, while their own DNA is protected by methylation at recognition sites.

Steps in Cloning a Gene

1. Isolate the gene of interest (e.g., human insulin cDNA, which lacks introns).

2. Add restriction sites to the ends of the gene using linker DNA.

3. Cut both the gene and plasmid vector with the same restriction enzyme.

4. Mix and ligate the DNA fragments to form recombinant plasmids.

5. Transform bacteria with the recombinant plasmid.

6. Select for bacteria containing the plasmid using antibiotic resistance.

Selection and Screening of Recombinant Bacteria

After transformation, bacteria are plated on media containing antibiotics. Only those with the plasmid survive. Additional screening (e.g., blue/white screening with X-gal and the lacZ gene) can distinguish recombinant from non-recombinant colonies.

• Blue colonies: Functional lacZ gene (no insert).

• White colonies: Disrupted lacZ gene (contain recombinant DNA).

Applications of Recombinant DNA Technology

• Production of therapeutic proteins (e.g., insulin, growth hormone, clotting factors).

• Recombinant vaccines.

• Industrial enzymes for brewing, baking, and bioremediation.

Summary Table: Key Features of Plasmid Vectors

Feature	Function
Origin of replication (ori)	Allows plasmid replication in bacteria
Selectable marker	Enables selection of transformed cells (e.g., antibiotic resistance)
Multiple cloning site (MCS)	Contains unique restriction sites for DNA insertion
Inducible promoter	Controls expression of inserted gene

Conclusion

Biotechnology and recombinant DNA technology have revolutionized genetics, medicine, and agriculture. By understanding and manipulating genetic material, scientists can produce valuable proteins, improve crops, and address environmental challenges. Mastery of these techniques is foundational for modern genetics and molecular biology.